Chris Connor, a life science senior research analyst at IDC, Health Industry Insights suggests that clinical trial management systems, CTMS, will play a critical role in Sarbanes-Oxley compliance. He also believes life science companies are turning to commercial software and technology subscription services to minimize their IT budget and regulatory exposure.
To review the article published in the Bio-ITWorld.com, click the link below.
http://www.bio-itworld.com/issues/2006/may/insights-outlook/